Delivery Order SPE2DB22D2206-SPE2DB25FKA49
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,699.90 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,728.21 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $13,400.56 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with an ultimate completion date of September 23, 2025. This competitive award, issued on September 22, 2025, utilizes a firm fixed-price contract type with no set-aside designation. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,019.94 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials, with a ceiling value of $11,019.75 and a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at one thousand fifty-seven dollars and fifty cents ($1,057.50) from the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply five hundred milligram vials of chlorothiazide sodium. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility, with completion by December 8, 2023. No set-aside designation was applied to this award made against an indefinite...
- The Defense Logistics Agency awarded a $3,238 delivery order contract to Amerisourcebergen Drug Corporation for chlorothiazide sodium 500 mg vials. As part of its pharmaceutical supply chain management responsibilities for the Department of Defense, DLA issued a requirement for this generic diuretic medication. Amerisourcebergen will deliver the vials from its Conshohocken, Pennsylvania facility on a firm fixed price basis, with performance spanning August 25-28, 2023. No subcontractors or...
- This federal contract award is for the delivery of 4565579169 units of the pharmaceutical product Chlorothiazide Sodium 500 mg Vials. The contract, valued at $7,205.22, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a firm fixed price and an ultimate completion date of August 27, 2024. The place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award, SPE2DB20D3103|SPE2DB23FM1E4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorothiazide Sodium 500 mg vials. The $1,030.01 fixed-price delivery order has a completion date of January 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of CHLOROTHIAZIDE SOD 500 MG VIALS, a pharmaceutical product, with a ceiling value of $3,635.63 and a period of performance through July 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp also...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA49Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials under a firm fixed-price contract valued at $19,694.00. The award was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. This delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from this same location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. The firm's federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 9/22/25 |